Arbutus Biopharma (ABUS) Non-cash Items (2009 - 2013)
Arbutus Biopharma recorded quarterly Non-cash Items of $1.3 million in Q4 2013, down 1.09% quarter-over-quarter from $1.3 million in Q4 2012, and down 1.09% year-over-year from $1.3 million in Q4 2012.
Arbutus Biopharma's Non-cash Items history runs 5 years deep, the most recent figure standing at $1.3 million for Q4 2013.
- In Q4 2013, Non-cash Items fell 1.09% year-over-year to $1.3 million; the TTM figure through Dec 2013 stood at $1.3 million (down 1.09% YoY), while the FY2013 annual figure was $6.8 million, up 8264.92% from the prior year.
- Non-cash Items came in at $1.3 million for Q4 2013 at Arbutus Biopharma, down from $1.3 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $1.3 million in Q4 2012 to a low of $1299.5 in Q4 2011.
- A 5-year average of $811329.5 and a median of $746692.2 in 2010 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items sank 99.83% in 2011 and surged 102039.23% in 2012, its largest moves.
- Arbutus Biopharma's Non-cash Items stood at $668562.8 in 2009, then gained by 11.69% to $746692.2 in 2010, then tumbled by 99.83% to $1299.5 in 2011, then soared by 102039.23% to $1.3 million in 2012, then dropped by 1.09% to $1.3 million in 2013.
- According to Business Quant data, Non-cash Items over the past three periods registered $1.3 million, $1.3 million, and $1299.5 for Q4 2013, Q4 2012, and Q4 2011 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 883.58 Mn | 883.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 1.31 Mn |
| Dec 31, 2013 | 1.31 Mn |
| Dec 31, 2012 | 1.33 Mn |
| Dec 31, 2012 | 1.33 Mn |
| Dec 31, 2011 | 1,299.45 |
| Dec 31, 2011 | 1,299.45 |
| Dec 31, 2010 | 746,692.23 |
| Dec 31, 2010 | 746,692.23 |
| Dec 31, 2009 | 668,562.80 |
| Dec 31, 2009 | 668,562.80 |